
Accelerating drug discovery and development through generative AI and automation for longevity and sustainability.
Visit WebsitePros
Cons
Insilico Medicine offers paid plans. Visit their website for current pricing details.
No reviews yet. Be the first to review Insilico Medicine!
Top alternatives based on features, pricing, and user needs.

AI community and platform

Open AI models
Developing Smart Targeted Radioligands for precision oncology using an AI-driven discovery engine.
Translating scientific discoveries into medical solutions for patients.
Developing breakthrough therapies for rare diseases with high unmet medical needs.
Developing inhaled therapeutics for severe respiratory diseases.
Developing innovative therapies for chronic and debilitating diseases.
Developing novel small molecule therapeutics for life-threatening diseases.
Insilico Medicine is an end-to-end generative AI-driven biotech company that uses its proprietary Pharma.AI platform to accelerate drug discovery and development, aiming to reduce the time and cost of bringing new medications to patients.
The website does not provide specific pricing information. Its software products are available for licensing, suggesting a paid model, likely enterprise-level or custom pricing.
No, Insilico Medicine's software products are available for licensing, indicating they are not free. There is an option to enroll for a free 'Disease Modeling and Target Discovery Course'.
Insilico Medicine is for pharmaceutical companies, biotech firms, research institutions, and scientists involved in drug discovery and development who are looking to leverage advanced generative AI and automation to enhance their processes, identify new targets, and design novel molecules more efficiently.
Source: insilico.com